IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. Their pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules. 

Biotechnology

IO Biotech

Mai-Britt Zocca

Misbah Sherwani

Qasim Ahmad

Devin Smith

Eric Faulkner

Amy Sullivan

Brian Burkavage

Ayako Wakatsuki Pedersen

Margaret Siemon-Hryczyk

Dan Mannix

Diane Mcdowell

Muhammad Al-Hajj

The Finance and Accounting team at IO Biotech manages the financial health of the company, ensuring accurate financial reporting, budgeting, and compliance with regulatory standards. They provide strategic financial guidance to support the development and commercialization of IO Biotech’s innovative cancer immunotherapies.

Finance and Accounting

Research and Development

Regulatory and Clinical Operations

Clinical Operations Team

Finance and Accounting

About

Team members

Other teams at IO Biotech

Research and Development

Regulatory and Clinical Operations

Clinical Operations Team